Ceruloplasmin is a serum ferroxidase enzyme essential for copper transport and the regulation of iron and copper metabolism.
Produced primarily in the liver, it transports 95% of blood copper and catalyzes the oxidation of ferrous iron to ferric iron, facilitating iron binding to transferrin.
Ceruloplasmin also acts as a positive acute-phase reactant during inflammation and regulates membrane lipid oxidation, linking it to atherosclerotic lesions.
Elevated levels are associated with inflammatory conditions, pregnancy, and certain diseases, while low levels can indicate disorders like Wilson disease and Menkes disease.
Testing for ceruloplasmin is crucial for diagnosing and managing these conditions, alongside related biomarkers and liver function tests.
Ceruloplasmin serves multiple essential functions within the human body, most notably in copper transport and in the regulation of iron and copper metabolism.
Ceruloplasmin is a vital serum ferroxidase enzyme responsible for transporting 95% of copper in the blood. Its primary role is catalyzing redox reactions in plasma.
In addition to its role in copper transport, ceruloplasmin also facilitates the conversion of ferrous iron into its ferric form, which is necessary for iron to bind to transferrin and be transported in the blood.
It is primarily produced in the liver, where copper is incorporated into the protein by P-type ATPase enzymes. Small amounts are also produced in immune cells.
Ceruloplasmin also acts as a positive acute-phase reactant, with levels rising in response to inflammation or cell injury.
Ceruloplasmin's primary role as a copper binding protein is to regulate and transport copper, an essential trace element that is required in appropriate amounts.
Copper is vital for red blood cell formation and preventing anemia by facilitating iron absorption. Copper enables proper nerve conduction and brain development through its involvement in neurotransmitter synthesis and myelination.
As a component of antioxidant enzymes, it protects cells from oxidative damage. Copper also contributes to connective tissue formation, energy production, and immune function.
However, excessive unbound copper has negative health effects. As a redox-active metal, unbound copper ions can catalyze the formation of reactive oxygen species, leading to oxidative stress and inflammation.
Ceruloplasmin mitigates these pro-oxidant effects by binding and safely transporting the majority of copper in the bloodstream, preventing undesirable redox cycling and oxidative damage. Additionally, ceruloplasmin's ferroxidase activity oxidizes ferrous iron, limiting iron-mediated reactive oxygen species generation.
The acute phase increase in ceruloplasmin during inflammation is a protective response to sequester free copper released from injured cells and curb its pro-oxidant and pro-inflammatory potential.
Thus, by tightly binding copper for transport and through its enzymatic activities, ceruloplasmin serves as a crucial antioxidant defense mechanism against copper's intrinsic ability to catalyze oxidative stress and exacerbate inflammatory conditions.
Ceruloplasmin is crucial in maintaining copper and iron homeostasis and is implicated in various health conditions.
Inflammatory conditions, pregnancy, estrogen therapy, and certain medications can elevate ceruloplasmin levels by raising copper levels. Levels can also rise in infection, trauma, and tissue damage, and in conditions like cardiovascular disease or rheumatoid arthritis. [6.]
Ceruloplasmin levels rise in a variety of inflammatory conditions where the increased ceruloplasmin helps to manage the excess free radicals produced during inflammation.
It also regulates membrane lipid oxidation and promotes LDL oxidation, linking it to atherosclerotic lesions.
Low levels may indicate disorders like Wilson disease, Menke disease, severe liver disease and aceruloplasminemia. Deficiency in ceruloplasmin can also lead to neurological disorders due to disrupted iron transport in the brain.
Testing for ceruloplasmin typically involves blood assays to measure serum levels.
Managing conditions associated with ceruloplasmin involves chelation therapy and monitoring for complications such as diabetes and liver damage.
A ceruloplasmin test may be ordered for an infant to diagnose rare inherited disorders of copper metabolism like Menkes disease, which presents with extremely low ceruloplasmin and copper levels, seizures, developmental delays, and unusual hair.
Early testing within the first month can allow prompt treatment to improve outcomes. Infants with a family history of Wilson disease, a condition causing copper accumulation, may also be screened for low ceruloplasmin levels.
Additionally, ceruloplasmin testing is warranted for babies exhibiting symptoms potentially related to copper metabolism disorders such as liver disease, neurological issues, or failure to thrive.
In cases of neonatal liver disease or hepatitis, low ceruloplasmin levels could indicate an underlying metabolic or genetic disorder affecting copper homeostasis.
Early diagnosis through ceruloplasmin testing is crucial for initiating appropriate management and preventing severe complications in these rare but serious conditions.
The Ceruloplasmin test typically involves a simple blood draw, where a sample is taken from a vein in the arm using standard venipuncture techniques.
The procedure is straightforward and requires no special preparation, although fasting may be required in some cases to ensure accuracy.
It’s also important for patients to inform their healthcare provider about any supplements or medications they are taking, as some substances can influence Ceruloplasmin levels.
Normal levels of ceruloplasmin can vary slightly between laboratories but typically falls between 20 and 50 milligrams per deciliter (mg/dL).
For example, one company reports the following values: [1.]
Males over 12 years old: 16-31 mg/dL
Females over 6 months old: 19-39 mg/d
It is important to note that levels of ceruloplasmin may vary according to age, gender, and in certain medical conditions or settings. Therefore, ceruloplasmin values are best interpreted alongside other markers including copper blood levels, inflammatory markers, and liver function tests.
High Ceruloplasmin levels might necessitate further investigation into potential causes such as chronic inflammation, infections, or neoplastic diseases.
High Ceruloplasmin levels often suggest an acute-phase reaction where the body is responding to stress, infection, or inflammation. In such cases, Ceruloplasmin acts as a positive acute-phase protein, increasing in concentration to manage increased metabolic demand and oxidative stress.
Specific conditions associated with elevated ceruloplasmin levels include rheumatoid arthritis, heart disease, and certain cancers, as well as estrogen therapy, pregnancy, and in the setting of stress, infection or inflammation. [2., 3., 5.]
Low Ceruloplasmin levels may point to a deficiency in copper intake or absorption, as seen in nutritional deficiencies or genetic disorders that affect copper transport, especially when coupled with clinical symptoms of copper deficiency or overload.
If nutritional deficiencies have been ruled out, genetic metabolic disorders like inherited aceruloplasminemia, Wilson's disease or Mencke’s disease should be considered.
Follow-up testing, including liver function tests and copper studies, might be recommended to pinpoint the underlying cause and guide treatment strategies.
In addition to Ceruloplasmin, several other biomarkers and tests are commonly used to provide a comprehensive overview of an individual's health, particularly in relation to metal metabolism and liver function.
Liver function tests including alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), bilirubin should be considered.
Ceruloplasmin is produced by the liver, and abnormal LFT results may indicate liver disease or dysfunction, which can affect ceruloplasmin synthesis and copper metabolism.
Ceruloplasmin binds and transports the majority of copper in the blood. Low ceruloplasmin levels are often accompanied by low serum copper levels, which can help diagnose conditions like Wilson disease or copper deficiency.
In Wilson disease, excess copper is excreted in the urine due to impaired biliary excretion. Elevated urine copper levels, along with low serum ceruloplasmin and copper levels, are diagnostic for Wilson disease.
Zinc is an essential cofactor for many enzymes involved in copper metabolism, including ceruloplasmin. Zinc excess or deficiency can lead to impaired copper utilization and ceruloplasmin synthesis.
Ceruloplasmin is an acute-phase reactant, and its levels can increase during inflammatory conditions or tissue injury. Assessing inflammatory markers can help interpret elevated ceruloplasmin levels.
Ceruloplasmin has ferroxidase activity, which is crucial for iron metabolism and transport. Abnormal iron levels may indicate a disruption in ceruloplasmin's role in iron homeostasis.
Click here to compare testing options and order tests for ceruloplasmin levels.
[1.] 001560: Ceruloplasmin | Labcorp. www.labcorp.com. https://www.labcorp.com/tests/001560/ceruloplasmin
[2.] Arenas de Larriva AP, Limia-Pérez L, Alcalá-Díaz JF, Alonso A, López-Miranda J, Delgado-Lista J. Ceruloplasmin and Coronary Heart Disease-A Systematic Review. Nutrients. 2020 Oct 21;12(10):3219. doi: 10.3390/nu12103219. PMID: 33096845; PMCID: PMC7589051.
[3.] Conforti A, Franco L, Menegale G, Milanino R, Piemonte G, Velo GP. Serum copper and ceruloplasmin levels in rheumatoid arthritis and degenerative joint disease and their pharmacological implications. Pharmacol Res Commun. 1983 Oct;15(9):859-67. doi: 10.1016/s0031-6989(83)80093-9. PMID: 6647528.
[4.] Denko CW. Protective role of ceruloplasmin in inflammation. Agents Actions. 1979 Oct;9(4):333-6. doi: 10.1007/BF01970657. PMID: 517330.
[5.] Koprivová H, Dienstbier Z, Sámal M, Foltýnová V. Ceruloplasmin in Hodgkin's disease. Neoplasma. 1982;29(3):333-40. PMID: 7133228.
[6.] Lopez MJ, Royer A, Shah NJ. Biochemistry, Ceruloplasmin. [Updated 2023 Feb 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554422/
[7.] National Institutes of Health. Office of Dietary Supplements - Copper. ods.od.nih.gov. Published December 6, 2019. https://ods.od.nih.gov/factsheets/Copper-Consumer/
[8.] National Research Council (US) Committee on Copper in Drinking Water. Copper in Drinking Water. Washington (DC): National Academies Press (US); 2000. 2, Physiological Role of Copper. Available from: https://www.ncbi.nlm.nih.gov/books/NBK225407/
[9.] Roeser HP, Lee GR, Nacht S, Cartwright GE. The role of ceruloplasmin in iron metabolism. J Clin Invest. 1970 Dec;49(12):2408-17. doi: 10.1172/JCI106460. PMID: 5480864; PMCID: PMC322742.